20th Jul 2010 07:00
Immunodiagnostics Systems Holdings PLC
Directors Dealings
Immunodiagnostic Systems Holdings plc ("the Company"), a leading producer of diagnostic testing kits, received notification on 19 July 2010 that on that day 1,729,517 ordinary shares of 2p each in the Company (the "Ordinary Shares"), were successfully placed with institutional investors by directors at a price of 725p. The shares were placed in response to demand from institutional shareholders.
The directors' dealings are summarised below:
|
Director |
Amount of shares held prior to sale |
Holding |
Amount of shares sold |
Resulting holding |
Resulting % |
|
|
|
|
|
|
|
|
David Evans |
522,458 |
1.88% |
365,008 |
157,450 |
0.57% |
|
Paul Hailes |
1,111,378 |
3.99% |
555,689 |
555,689 |
1.99% |
|
Tony Wilks |
58,820 |
0.21% |
58,820 |
0 |
0.00% |
|
Roger Duggan |
2,276,187 |
8.17% |
750,000 |
1,526,187 |
5.48% |
The above holding calculations are based on the Company's issued share capital of 27,857,240 Ordinary Shares in the Company. The Company does not hold any Ordinary Shares in Treasury.
Contacts:
|
Immunodiagnostic Systems Holdings PLC |
Tel: 0191 519 0660 |
|
Roger Duggan, CEO |
|
|
Paul Hailes, Finance Director |
|
|
|
|
|
Brewin Dolphin Investment Banking |
Tel: 0845 213 4730 |
|
Andrew Emmott Richard Jones |
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8787 |
|
Paul McManus |
|
Related Shares:
IDH.L